Biogen Inc. (BIIB)

199.65
6.56 3.40
NASDAQ
Prev Close 193.09
Open 195.33
Day Low/High 194.50 / 199.78
52 Wk Low/High 187.16 / 468.55
Volume 972.07K
Exchange NASDAQ
Shares Outstanding 146.45B
Market Cap 28.66B
P/E Ratio 8.89
Div & Yield N.A. (N.A)

Janet Yellen, Stock Market Commentator?

It's not the Fed chief's place.

Here's What's Driving Biotech

And it's not the favorable macroeconomic climate.

I'm Going to Keep Riding These Horses

Biogen miss no reason to abandon big 4 of Big Pharma.

Dig Into NXP, Biogen and Sprouts Shares Says Eaton Vance Manager

Dig Into NXP, Biogen and Sprouts Shares Says Eaton Vance Manager

Apple provides a fantastic platform, but there are other places to profit in the connected device arena such as NXP Semiconductors.

Biogen, American Airlines: What to Watch on Wall Street April 24

Biogen, American Airlines: What to Watch on Wall Street April 24

For Friday, April 24 we watch for quarterly financial results from drug maker Biogen (BIIB), copy machine company Xerox (XRX), and American Airlines (AAL).

Market Wrap: Nasdaq Hits Record High

Telecom, utility and energy names led the way higher Thursday.

Gilead May Be the Cure for the Blues

Gilead May Be the Cure for the Blues

Gilead's Relative Strength Index slope is very strong.

Gilead May Be the Cure for the Blues

Gilead May Be the Cure for the Blues

Gilead's Relative Strength Index slope is very strong.

Mylan Deal the Rx for Drug Stocks

Mylan Deal the Rx for Drug Stocks

Even the second-tier biotechs are taking off.

In the Middle Zone

The market is neither making progress nor shifting into a downtrend.

The Fibocall: Biogen

The Fibocall: Biogen

After share price falls from March high, it may be ready to bounce.

Answering Your Tweets

An answer to those asking me what's worth buying.

Biogen Is a Cash Machine

But wait for a pullback before getting in.

Today Didn't Make a Lot of Sense

Good buys kept getting overlooked.

How I Play the Biotechs

How I Play the Biotechs

A strategy to immunize biotech investors from regret.

A Healthy Dose of Biogen

Its Alzheimer's treatment impressed, but dosing questions remain.

Slow and Thin

If it doesn't heat up, traders may start selling more aggressively.

Biogen Idec downgraded at Stifel

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Biotech Stocks at a Crossroad

Own them, or take something off the table?

A Game of 'Catch-Up'

It was encouraging to see the market broaden out like this.

I'm Making a Don't-Buy Call on Biotech

I'm Making a Don't-Buy Call on Biotech

I really like the stocks. But I also like making money on stocks.

Biotech Is Getting Frothy

The market opened on a very strong note and Biogen Idec is up big after announcing study of its experimental drug for Alzheimer's disease had exceeded expectations.  The whole biotech sector is having another strong day after yesterday's huge outper...

The Next Biotech Breakout?

As always, I am happy to be standing in for Doug Kass today on the Daily Diary (this Friday from sunny Miami). It looks like it will be an up open to talk about based on early market futures. The euro is heading towards its best week in 18 months, e...

These Stocks Get Benefit of the Doubt

Market backtracks on skepticism over biotechs.

There's Action Below the Surface

Biotechs are still bubbly in 'stock pickers' market.

Remarkable Biotech Runs Continue

Remarkable Biotech Runs Continue

A Fed-related dip may be your only hope to get in lower.

Market Rewards Biotech Latecomers

It shouldn't be possible, but it never seems too late to get in.

Bears Shouldn't Get Too Cocky

There's still plenty of action out there.

The Biotechs Are Feeling Better

The Biotechs Are Feeling Better

Sector could regain its leadership role.